Skip to content
10-Q

Quarterly Report

QLY BIOTECH GROUP CORP.

0001477932-20-003991

← back to feed
Filed
Jul 15, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Jul 14, 2020 3M sh
Current Liabilities Q3 2020 · May 31, 2020 $7.8K
Current Liabilities Q3 2020 · Aug 31, 2019 $2.98K
Total Liabilities Q3 2020 · May 31, 2020 $7.8K
Total Liabilities Q3 2020 · Aug 31, 2019 $2.98K
Current Assets Q3 2020 · May 31, 2020 $2.16K
Current Assets Q3 2020 · Aug 31, 2019 $5K
Total Assets Q3 2020 · May 31, 2020 $6.29K
Total Assets Q3 2020 · Aug 31, 2019 $5K
Capex Q3 2020 · May 31, 2019 $0
Operating Cash Flow Q3 2020 · May 31, 2019 −$978
Cash And Equivalents Q3 2020 · May 31, 2019 $5K
Cash And Equivalents Q3 2020 · Sep 19, 2018 $0
Stockholders Equity Q3 2020 · May 31, 2019 $2.02K
Stockholders Equity Q3 2020 · Sep 20, 2018 $0
Sga Expense Q3 2020 · May 31, 2019 $0
Sga Expense Q3 2020 · May 31, 2019 $978
Net Income Q3 2020 · May 31, 2019 $0
Net Income Q3 2020 · May 31, 2019 −$978
Net Income Q3 2020 · May 31, 2019 −$978
Revenue Q3 2020 · May 31, 2019 $0
Revenue Q3 2020 · May 31, 2019 $0